Biomarker development in the precision medicine era: lung cancer as a case study

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Nature Reviews. Cancer

• Publication date

  2016-07-08

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrc.2016.56PMID 27388699PMCID PMC6662593
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Leading Edge Perspective Microbiome and Anticancer Immunosurveillance

  2016cited by this paper
• Lung Cancer and Personalized Medicine

  2016cited by this paper
• Predictive Markers for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Lung Cancer.

  2016cited by this paper
• Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

  2016cited by this paper
• Emerging applications of metabolomics in drug discovery and precision medicine

  2016cited by this paper
• Epidemiology of Lung Cancer.

  2016cited by this paper
• Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.

  2016cited by this paper
• Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas

  2016cited by this paper
• Pulmonary nodules and CT screening: the past, present and future

  2016cited by this paper
• Long Noncoding RNAs in Cancer Pathways.

  2016cited by this paper
• Immunotherapy Combined or Sequenced With Targeted Therapy in the Treatment of Solid Tumors: Current Perspectives.

  2016cited by this paper
• Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management. Preface.

  2016cited by this paper
• Biomarkers and targeted systemic therapies in advanced non-small cell lung cancer.

  2015cited by this paper
• NMR metabolomics of human lung tumours reveals distinct metabolic signatures for adenocarcinoma and squamous cell carcinoma.

  2015cited by this paper
• Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis.

  2015cited by this paper
• Regulating laboratory-developed tests: devil will be in details.

  2015cited by this paper
• RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics

  2015cited by this paper
• Systemic Metabolomic Changes in Blood Samples of Lung Cancer Patients Identified by Gas Chromatography Time-of-Flight Mass Spectrometry

  2015cited by this paper
• PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy

  2015cited by this paper
• A new initiative on precision medicine.

  2015cited by this paper
• Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer.

  2015cited by this paper
• Verification of the biomarker candidates for non-small-cell lung cancer using a targeted proteomics approach.

  2015cited by this paper
• Understanding multicellular function and disease with human tissue-specific networks

  2015cited by this paper
• Lung cancer screening poised to expand.

  2015cited by this paper
• Objective measurement and clinical significance of TILs in non-small cell lung cancer.

  2015cited by this paper
• Personalized medicine: Time for one-person trials

  2015cited by this paper
• Remarks by the President in State of the Union Address: January 20, 2015

  2015cited by this paper
• Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma: A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma

  2015cited by this paper
• Genome-wide Gene–Asbestos Exposure Interaction Association Study Identifies a Common Susceptibility Variant on 22q13.31 Associated with Lung Cancer Risk

  2015cited by this paper
• Personalized biomarkers to monitor disease progression in advanced non-small-cell lung cancer patients treated with icotinib.

  2015cited by this paper
• Investigation of Metabolomic Blood Biomarkers for Detection of Adenocarcinoma Lung Cancer

  2015cited by this paper
• Self‐reported Tobacco use does not correlate with carcinogen exposure in smokers with head and neck cancer

  2015cited by this paper
• Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan

  2015cited by this paper
• Metabolomic Markers of Altered Nucleotide Metabolism in Early Stage Adenocarcinoma

  2015cited by this paper
• Quantification of concentration and assessment of EGFR mutation in circulating DNA

  2015cited by this paper
• An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers

  2015cited by this paper
• Advances in molecular biology of lung disease: aiming for precision therapy in non-small cell lung cancer.

  2015cited by this paper
• Biomarkers of tobacco smoke exposure in racial/ethnic groups at high risk for lung cancer.

  2015cited by this paper
• Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.

  2014cited by this paper
• Efficiency of the Therascreen® RGQ PCR kit for the detection of EGFR mutations in non-small cell lung carcinomas.

  2014cited by this paper
• Diagnostic value of circulating free DNA for the detection of EGFR mutation status in NSCLC: a systematic review and meta-analysis

  2014cited by this paper
• Comprehensive molecular profiling of lung adenocarcinoma

  2014cited by this paper
• Smoking, p53 Mutation, and Lung Cancer

  2014cited by this paper
• Serum metabolic profiling study of lung cancer using ultra high performance liquid chromatography/quadrupole time-of-flight mass spectrometry.

  2014cited by this paper
• Processing faecal samples: a step forward for standards in microbial community analysis

  2014cited by this paper
• Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer.

  2014cited by this paper
• Tracking Genomic Cancer Evolution for Precision Medicine: The Lung TRACERx Study

  2014cited by this paper
• Cancer Drug Development and the Evolving Regulatory Framework for Companion Diagnostics in the European Union

  2014cited by this paper
• FDA Perspective on Companion Diagnostics: An Evolving Paradigm

  2014cited by this paper
• A brave new world: the lung microbiota in an era of change.

  2014cited by this paper
• The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts

  2014cited by this paper
• Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome

  2014cited by this paper
• Epigenetic biomarkers in lung cancer.

  2014cited by this paper
• A Combined Prognostic Serum Interleukin-8 and Interleukin-6 Classifier for Stage 1 Lung Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

  2014cited by this paper
• Assessing the clinical utility of cancer genomic and proteomic data across tumor types

  2014cited by this paper
• Biomarkers That Currently Affect Clinical Practice in Lung Cancer: EGFR, ALK, MET, ROS-1, and KRAS

  2014cited by this paper
• Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact

  2014cited by this paper
• Similarity network fusion for aggregating data types on a genomic scale

  2014cited by this paper
• The UK Lung Screen (UKLS): Demographic Profile of First 88,897 Approaches Provides Recommendations for Population Screening

  2014cited by this paper
• Similarities and Differences in the Oncology Drug Approval Process between FDA and European Union with Emphasis on In Vitro Companion Diagnostics

  2014cited by this paper
• The potential role of lung microbiota in lung cancer attributed to household coal burning exposures

  2014cited by this paper
• Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design

  2014cited by this paper
• Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges

  2013cited by this paper
• A prognostic DNA methylation signature for stage I non-small-cell lung cancer.

  2013cited by this paper
• Annual number of lung cancer deaths potentially avertable by screening in the United States

  2013cited by this paper
• The early detection research network: 10-year outlook.

  2013cited by this paper
• Development of a Dual-Index Sequencing Strategy and Curation Pipeline for Analyzing Amplicon Sequence Data on the MiSeq Illumina Sequencing Platform

  2013cited by this paper
• Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

  2013cited by this paper
• Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the Southern Swedish Lung Cancer Study.

  2013cited by this paper
• Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

  2013cited by this paper
• Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.

  2013cited by this paper
• Statistical and practical considerations for clinical evaluation of predictive biomarkers.

  2013cited by this paper
• Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma.

  2013cited by this paper
• Genomic landscape of non-small-cell lung cancer in smokers and never-smokers

  2013cited by this paper
• A High-Dimensional, Deep-Sequencing Study of Lung Adenocarcinoma in Female Never-Smokers

  2013cited by this paper
• Passing Messages between Biological Networks to Refine Predicted Interactions

  2013cited by this paper
• Lung carcinogenesis by tobacco smoke

  2012cited by this paper
• Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.

  2012cited by this paper
• Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

  2012cited by this paper
• Comprehensive genomic characterization of squamous cell lung cancers

  2012cited by this paper
• Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

  2012cited by this paper
• Commercialization of microfluidic point-of-care diagnostic devices.

  2012cited by this paper
• MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response

  2012cited by this paper
• The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary Disease

  2012cited by this paper
• A novel approach for biomarker selection and the integration of repeated measures experiments from two assays

  2012cited by this paper
• Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration

  2012cited by this paper
• Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

  2012cited by this paper
• Association between Single Nucleotide Polymorphisms (SNPs) and Toxicity of Advanced Non-Small-Cell Lung Cancer Patients Treated with Chemotherapy

  2012cited by this paper
• Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing.

  2012cited by this paper
• Storage conditions of intestinal microbiota matter in metagenomic analysis

  2012cited by this paper
• Genomic analysis identifies association of Fusobacterium with colorectal carcinoma.

  2012cited by this paper
• Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma.

  2012cited by this paper
• C-reactive protein as a monitor of chemotherapy response in advanced non-small cell lung cancer (CML study).

  2012cited by this paper
• Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?

  2012cited by this paper
• Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration

  2012cited by this paper
• International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

  2012cited by this paper
• Genomic landscape of non-small cell lung cancer in smokers and never-smokers.

  2012cited by this paper
• Reduced lung-cancer mortality with low-dose computed tomographic screening.

  2011cited by this paper
• Cigarette smoke impairs airway epithelial barrier function and cell–cell contact recovery

  2011cited by this paper
• A metabolomic approach to lung cancer.

  2011cited by this paper

• The role of microRNAs in modulating Wnt signaling pathway dynamics and their therapeutic implications in non-small cell lung cancer.

  2026cites this paper
• Evaluation of ICAM and VCAM as biomarkers in serum and bronchoscopic lavage samples of lung cancer patients.

  2026cites this paper
• Tumour markers and evidence-based pathology.

  2026cites this paper
• Enabling global-scale nucleic acid repositories through versatile, scalable biochemical selection from room-temperature archives.

  2026cites this paper
• A prognostic nomogram for overall survival in patients with driver-gene-negative lung adenocarcinoma and its biological basis

  2026cites this paper
• Transcriptomic integration and functional validation reveal PLAC8, CLCA4, and ADAMDEC1 as key biomarkers linking periodontitis and colorectal cancer

  2026cites this paper
• Multilayer metabolomic integration reveals bioenergetic disruption in Long COVID

  2026cites this paper
• Dual-Mode Tumor Diagnosis and Guided Precise Photodynamic Therapy Based on MicroRNA Fluorescence Signal Amplification and Magnetic Resonance Imaging.

  2025cites this paper
• The X-Linked Tumor Suppressor TSPX Regulates Genes Involved in the EGFR Signaling Pathway and Cell Viability to Suppress Lung Adenocarcinoma

  2025cites this paper
• Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives.

  2025cites this paper
• Multi-omics strategies for biomarker discovery and application in personalized oncology

  2025cites this paper
• Refining biomarker design in light of cancer evolution

  2025cites this paper
• Machine learning-enhanced direct mass spectrometry analysis of non-volatile breath metabolites for rapid and accurate lung cancer screening.

  2025cites this paper
• A multistage, multitask transformer-based framework for multi-disease diagnosis and prediction using personal proteomes

  2025cites this paper
• A Pseudo-Value Approach to Causal Deep Learning of Semi-Competing Risks.

  2025cites this paper
• Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma

  2025cites this paper
• Evaluating the Polypharmacological potential of cosmetic preservative imidurea against lung Cancer-associated EGFR, CDK2, STAT3, BCL2, p53, and ABCB1 proteins.

  2025cites this paper
• A pan-cancer, pan-treatment model for predicting drug responses from patient-derived xenografts

  2025cites this paper
• Biologics for novel driver altered non-small cell lung cancer: potential and pitfalls.

  2025cites this paper
• A Pan-Cancer, Pan-Treatment (PCPT) Model For Predicting Drug Responses From Patient-Derived Xenografts With Application To Cancer Types With Sparse Training Data

  2025cites this paper
• A quantitative prediction method utilizing whole omics data for biosensing

  2025cites this paper
• A Multi‐Input Molecular Classifier Based on Digital DNA Strand Displacement for Disease Diagnostics

  2025cites this paper
• Molecular signatures and emerging therapeutic targets in schizophrenia: A biomarker-centric perspective in psychiatric disorders.

  2025cites this paper
• The Role of PLIN3 in Prognosis and Tumor-Associated Macrophage Infiltration: A Pan-Cancer Analysis

  2025cites this paper
• Mental Health Interventions in Everyday Life

  2025cites this paper
• Endogenous and/or exogenous origin of phenolic metabolites in humans (the ENDOPHENOL project): study protocol for a randomized, controlled, crossover trial

  2025cites this paper
• Development of a Prognostic m6A-Related lncRNA Signature and Functional Validation of FAM83A-AS1 in Lung Adenocarcinoma

  2025cites this paper
• Near‐Infrared Photoaccelerated MicroRNA Response for Image‐Guided Photodynamic‐Chemodynamic Synergistic Cancer Therapy via Nanoprobe Programmed Disassembly

  2025cites this paper
• Construction of a Self-Assembled DNA Nanofirework for Signal Amplification and Intracellular miRNA Imaging.

  2025cites this paper
• Hierarchical taxonomy of psychopathology and personalized mental health treatment selection

  2025cites this paper
• Mapping the future: bibliometric analysis of omics research trends in non-small cell lung cancer

  2025cites this paper
• Retrieval-augmented generation for generative artificial intelligence in health care

  2025cites this paper
• Pretrained transformers applied to clinical studies improve predictions of treatment efficacy and associated biomarkers

  2025cites this paper
• Integrated Machine Learning Algorithms-Enhanced Predication for Cervical Cancer from Mass Spectrometry-Based Proteomics Data

  2025cites this paper
• Point-of-care mass spectrometry metabolomic analysis enabling intraoperative brain tumor diagnosis

  2025cites this paper
• Quantum intelligence in drug discovery: Advancing insights with quantum machine learning.

  2025cites this paper
• Precision Medicine for Cancer and Health Equity in Latin America: Generating Understanding for Policy and Health System Shaping

  2025cites this paper
• Next-Generation Sequencing (NGS) in non-small cell lung carcinoma: A real-world experience in the public health system of Galicia (Northwest Spain)

  2025cites this paper
• Multi-omics and bulk sequencing analyses reveal the roles of prognosis and immune aspects of super-enhancer-induced ZBED2 in pan-cancer.

  2025cites this paper
• MetaPredictomics

  2025cites this paper
• City scale related to epidermal growth factor receptor mutations status in Chinese non-small cell lung cancer

  2025cites this paper
• Viral Oncogenesis Biomarkers in Diagnostics: From Tumor Viruses to Precision Cancer Medicine

  2024cites this paper
• The Role of Epistemic Communities in Formulating EU Policy: The PrecisionTox Project

  2024cites this paper
• Artificial intelligence for cardiovascular disease risk assessment in personalised framework: a scoping review

  2024cites this paper
• Circular RNA circ_001621 acts as a tumor promoter in lung cancer by regulating the miR-199a-3p/GREM1 axis

  2024cites this paper
• Emerging Biomarkers in Metabolomics: Advancements in Precision Health and Disease Diagnosis

  2024cites this paper
• Evolving Precision First-Line Systemic Treatment for Patients with Unresectable Non-Small Cell Lung Cancer

  2024cites this paper
• Primary Stereotactic Body Radiotherapy for Spinal Bone Metastases From Lung Adenocarcinoma.

  2024cites this paper
• Specifying the choice of EGFR-TKI based on brain metastatic status for advanced NSCLC with EGFR p.L861Q mutation

  2024cites this paper
• Older patients affected by COVID-19: investigating the existence of biological phenotypes

  2024cites this paper
• TransCDR: a deep learning model for enhancing the generalizability of drug activity prediction through transfer learning and multimodal data fusion

  2024cites this paper
• Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program

  2024cites this paper
• Prognostic Value of IMP3 Expression in Squamous Cervical Cancer

  2024cites this paper
• Dysregulation of the DRAIC/SBK1 Axis Promotes Lung Cancer Progression

  2024cites this paper
• Multiregional transcriptomic profiling provides improved prognostic insight in localized non-small cell lung cancer

  2024cites this paper
• Liquid Biopsy versus CT: Comparison of Tumor Burden Quantification in 1065 Patients with Metastases.

  2024cites this paper
• Equivocating and Deliberating on the Probability of COVID-19 Infection Serving as a Risk Factor for Lung Cancer and Common Molecular Pathways Serving as a Link

  2024cites this paper
• Integrating omics data for personalized medicine in treating psoriasis

  2024cites this paper
• Identification of Time-Series Pattern Marker in Its Application to Mortality Analysis of Pneumonia Patients in Intensive Care Unit

  2024cites this paper
• The relationship between metabolite mediated immune regulatory imbalance and the occurrence of malignant tumors of bone and articular cartilage: a Mendelian randomization study

  2024cites this paper
• Statistical Methods Applied to Gene Expression Data to Explore Cancer Features

  2024cites this paper
• ssMutPA: single-sample mutation-based pathway analysis approach for cancer precision medicine

  2024cites this paper
• Metabolic diagnosis of cancer cachexia

  2024cites this paper
• Retrieval-Augmented Generation for Generative Artificial Intelligence in Medicine

  2024cites this paper
• Enhancing Biomarker Detection in Human Serum for Lung Cancer Diagnosis: Aqueous Biphasic Systems for Simultaneous Depletion of High-Abundance Proteins and Efficient Extraction of CYFRA 21-1

  2024cites this paper
• Expression and prognostic value of cell‐cycle‐associated genes in lung squamous cell carcinoma

  2024cites this paper
• An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives

  2024cites this paper
• Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer

  2024cites this paper
• Fluorescent Probes for Disease Diagnosis

  2024cites this paper
• CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway.

  2024cites this paper
• Tumor biomarkers for diagnosis, prognosis and targeted therapy

  2024cites this paper
• Enabling global-scale nucleic acid repositories through versatile, scalable biochemical selection from room-temperature archives

  2024cites this paper
• The status quo and influencing factors of clinical research nurses’ participation in preoperative blood sampling in patients with pulmonary nodules

  2024cites this paper
• Identification of lung adenocarcinoma subtypes and a prognostic signature based on activity changes of the hallmark and immunologic gene sets

  2024cites this paper
• The Use of Big Data in Personalized Healthcare to Reduce Inventory Waste and Optimize Patient Treatment

  2024cites this paper
• DNA‐Programmed (De)Hybridization of Near‐Infrared Photosensitized UCNP‐QDs‐GNPs Nanoprobes for MicroRNA Imaging and Image‐Guided Cancer Therapy

  2024cites this paper
• Rapid Volumetric Bioprinting of Decellularized Extracellular Matrix Bioinks

  2024cites this paper
• Co-occurring EGFR p.E709X mutation Mediates Primary Resistance to the Third-generation EGFR-TKIs in EGFR p.G719X-mutant Patients with Advanced NSCLC.

  2024cites this paper
• Omics-based molecular classifications empowering in precision oncology

  2024cites this paper
• CD74 as a prognostic and M1 macrophage infiltration marker in a comprehensive pan-cancer analysis

  2024cites this paper
• Extracellular vesicle‐based biomarker in head and neck cancer: prospects and challenges

  2024cites this paper
• Tailor-made molecular imprints for biological event intervention.

  2024cites this paper
• Ultrasensitive Point-of-Care Detection of Protein Markers Using an Aptamer-CRISPR/Cas12a-Regulated Liquid Crystal Sensor (ALICS).

  2024cites this paper
• Community cohesion looseness in gene networks reveals individualized drug targets and resistance

  2024cites this paper
• Saliva‑microbiome‑derived signatures: expected to become a potential biomarker for pulmonary nodules (MCEPN-1)

  2024cites this paper
• Current Evidence for a Lung Cancer Screening Program

  2024cites this paper
• Combinatory electric-field-guided deposition for spatial microparticles patterning

  2024cites this paper
• Identifying Network Biomarkers in Early Diagnosis of Hepatocellular Carcinoma via miRNA–Gene Interaction Network Analysis

  2023cites this paper
• SARS-CoV-2 infection as a potential risk factor for the development of cancer

  2023cites this paper
• Enhancing Translational Medicine with Deep-Learning Transformers: Unveiling Biological Insights and Improving Predictions of Treatment Efficacy

  2023cites this paper
• Cancer management during the COVID-19 world pandemic

  2023cites this paper
• Peptidome data-driven comprehensive individualized monitoring of membranous nephropathy with machine learning

  2023cites this paper
• Synthetic Gene Circuit-Based Assay with Multilevel Switch Enables Background-Free and Absolute Quantification of Circulating Tumor DNA

  2023cites this paper
• Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity

  2023cites this paper
• Oncogenic Proteomics Approaches for Translational Research and HIV-Associated Malignancy Mechanisms

  2023influential citation
• Multidimensional biomarkers for multiple system atrophy: an update and future directions

  2023cites this paper
• Construction of an ATP-Activated Y-Shape DNA Probe for Smart miRNA Imaging in Living Cells

  2023cites this paper
• DoSurvive: A webtool for investigating the prognostic power of a single or combined cancer biomarker

  2023cites this paper
• Functional materials of 3D bioprinting for wound dressings and skin tissue engineering applications: A review

  2023cites this paper
• A DNA Nano Firework for Imaging and Inhibitor Screening of Flap Endonuclease 1 in Living Cells.

  2023cites this paper